These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1609034)

  • 61. Plasma homovanillic acid in untreated schizophrenia--relationship with symptomatology and sex.
    Zhang ZJ; Peet M; Ramchand CN; Shah S; Reynolds GP
    J Psychiatr Res; 2001; 35(1):23-8. PubMed ID: 11287053
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tardive dyskinesia in schizophrenia is associated with prolactin-related sexual disturbances.
    Tenback DE; van Harten PN; Slooff CJ; van Os J;
    Neuropsychopharmacology; 2006 Aug; 31(8):1832-7. PubMed ID: 16482082
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of long-term neuroleptic treatment on prolactin and norepinephrine levels in serum of chronic schizophrenics: relations to psychopathology and extrapyramidal symptoms.
    Naber D; Finkbeiner C; Fischer B; Zander KJ; Ackenheil M
    Neuropsychobiology; 1980; 6(4):181-9. PubMed ID: 6104798
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia.
    Davidson M; Kahn RS; Stern RG; Hirschowitz J; Apter S; Knott P; Davis KL
    Psychiatry Res; 1993 Feb; 46(2):151-63. PubMed ID: 8483974
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prediction of changes in memory performance by plasma homovanillic acid levels in clozapine-treated patients with schizophrenia.
    Sumiyoshi T; Roy A; Kim CH; Jayathilake K; Lee MA; Sumiyoshi C; Meltzer HY
    Psychopharmacology (Berl); 2004 Dec; 177(1-2):79-83. PubMed ID: 15179543
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tardive dyskinesia predicts prolactin response to buspirone challenge in people with schizophrenia.
    Shim JC; Kim YH; Kelly DL; Lee JG; Conley RR
    J Neuropsychiatry Clin Neurosci; 2005; 17(2):221-6. PubMed ID: 15939977
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Short-term haloperidol administration acutely elevates human plasma homovanillic acid concentration.
    Davidson M; Giordani AB; Mohs RC; Horvath TB; Davis BM; Powchik P; Davis KL
    Arch Gen Psychiatry; 1987 Feb; 44(2):189-90. PubMed ID: 3813816
    [No Abstract]   [Full Text] [Related]  

  • 68. Neuroleptic treatment, symptoms of schizophrenia, and plasma homovanillic acid concentrations revisited.
    Volavka J; Douyon R; Convit A; Czobor P; Cooper TB
    Arch Gen Psychiatry; 1992 Dec; 49(12):999-1000. PubMed ID: 1449388
    [No Abstract]   [Full Text] [Related]  

  • 69. Prolactin bioassay in schizophrenia before and after neuroleptics.
    Peabody CA; Warner MD; Griffin M; Boutros NN; Worsley IG; Friesen HG
    Psychiatry Res; 1992 Mar; 41(3):249-55. PubMed ID: 1594711
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Variability of plasma homovanillic acid over 13 months in patients with schizophrenia; relationship with the clinical response and the Wisconsin card sort test.
    Zumárraga M; González-Torres MA; Arrue A; Dávila R; Dávila W; Inchausti L; Pérez-Cabeza L; Fernández-Rivas A; Bustamante S; Basterreche N; Guimón J
    Neurochem Res; 2011 Aug; 36(8):1336-43. PubMed ID: 21475956
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorder.
    Chou JC; Douyon R; Czobor P; Volavka J; Cooper TB
    Psychiatry Res; 1998 Oct; 81(1):51-5. PubMed ID: 9829650
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Possible associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated male schizophrenics.
    Csernansky JG; Prosser E; Kaplan J; Mahler E; Berger PA; Hollister LE
    Biol Psychiatry; 1986 Jun; 21(7):632-42. PubMed ID: 2871874
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pretreatment plasma homovanillic acid in schizophrenia and schizoaffective disorder: the influence of demographic variables and the inpatient drug-free period.
    Sharma RP; Javaid JI; Davis JM; Janicak PG
    Biol Psychiatry; 1998 Sep; 44(6):488-92. PubMed ID: 9777181
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients.
    Rao ML; Brown WA
    Psychopharmacology (Berl); 1987; 93(2):237-42. PubMed ID: 2892222
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Apomorphine has no effect on plasma homovanillic acid in schizophrenic patients.
    Davidson M; Kendler KS; Davis BM; Horvath TB; Mohs RC; Davis KL
    Psychiatry Res; 1985 Oct; 16(2):95-9. PubMed ID: 3865258
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge.
    Kolakowska T; Braddock L; Wiles D; Franklin M; Gelder M
    Br J Psychiatry; 1981 Nov; 139():400-4. PubMed ID: 6120731
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Plasma homovanillic acid in the prodromal phase of schizophrenia.
    Sumiyoshi T; Kurachi M; Kurokawa K; Yotsutsuji T; Uehara T; Itoh H; Saitoh O
    Biol Psychiatry; 2000 Mar; 47(5):428-33. PubMed ID: 10704954
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Delusional disorder: molecular genetic evidence for dopamine psychosis.
    Morimoto K; Miyatake R; Nakamura M; Watanabe T; Hirao T; Suwaki H
    Neuropsychopharmacology; 2002 Jun; 26(6):794-801. PubMed ID: 12007750
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses.
    Levy MI; Davis BM; Mohs RC; Kendler KS; Mathé AA; Trigos G; Horvath TB; Davis KL
    Arch Gen Psychiatry; 1984 May; 41(5):520-4. PubMed ID: 6372737
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of single dose haloperidol administration on plasma homovanillic acid levels in normal subjects.
    Magliozzi JR; Doran AR; Gietzen DW; Olson AM; Maclin EL; Tuason VB
    Psychiatry Res; 1993 May; 47(2):141-9. PubMed ID: 8341767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.